Association of cytotoxic T lymphocyte-associated antigen 4 gene single nucleotide polymorphism with type 1 diabetes mellitus in Madurai population of Southern India

Indian Journal of Human Genetics

Volumn 17, Issue 2, 2011, Pages 85-89

  Philip, Beatrice ^a   Isabel, W ^a  

^a LADY DOAK COLLEGE   (India)

Author keywords

Autoimmune disease; Gene polymorphism; polymerase chain reaction; restriction enzyme; restriction fragment length polymorphism; T cell receptor; Type 1 diabetes; Cytotoxic T lymphocyte associated antigen 4 gene

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GENOMIC DNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; HUMAN; INDIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 80155213231     PISSN: 09716866     EISSN: 1998362X     Source Type: Journal    
DOI: 10.4103/0971-6866.86189     Document Type: Article

References (23)

1. Dariavach P, Mattéi MG, Golstein P, Lefranc MP. Human Ig superfamily CTLA-4 gene: Chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol 1988;18:1901-5. (Pubitemid 19046203)
2. Deichmann K, Heinzmann A, Brüggenolte E, Forster J, Kuehr J. An Mse I RFLP in the human CTLA-4 promoter. Biochem Biophys Res CoMun 1996;225:817-8. (Pubitemid 26319188)
3. Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 1996;5:1075-80. (Pubitemid 26232296)
4. Harper K, Balzano C, Rouvier E, Mattéi MG, Luciani MF, Golstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 1991;147:1037-44.
5. Gossain VV. Insulin analogs and intensive insulin therapy in type 1 diabetes. Int J Diabetes Dev Ctries 2003;23:26-36.
6. Arikan E, Sabuncu T, Ozu ME, Hatremia H. The characterization of latent autoimmunediabetes in adults and its relation with chronic complication in metabolically controlled Turkish patients with type 2 diabetes mellitus. J Diabetes Complications 2004;19:254-8. (Pubitemid 41169821)
7. Ramachandra A, Snehalatha C, Krishnaswami CV. Incidence of IDDM in urban population in Southern India. Madras IDDM registry group South India. Diabetes Res Clin Pract 1996;34:79-82. (Pubitemid 27076899)
8. Radha V, Vimaleswaran KS, Deepa R, Mohan V. The genetics of Diabetes mellitus. Indian J Med Res 2003;117:225-35.
9. Mehra NK, Kumar N, Kaur G, Kanga U, Tandon N. Biomarkers of susceptibility to type 1 diabetes with special reference to Indian population. Indian J Med Res 2007;125:321-44. (Pubitemid 46812933)
10. SiMonds SJ, Gough SC. Genetic insights into disease mechanism of autoiMunity. Br Med Bull 2005;71:93-113.
11. Sawka AM, Boulos P, Talib AS, Gafni A, Thabane L, Papaioannou A, et al. Low socioeconomic status and increased risk of severe hypoglycemia in type 1 diabetes: A systematic literature review. Can J Diabetes 2007;31:233-41. (Pubitemid 47523073)
12. Brunet JF, Denizot F, Luciani MF. A new member of the iMunoglobulin superfamily-CTLA-4. Nature 1987;328:267-70.
13. Kucharska AM, Gorska E, Wasik M, Pyrzak B, Demkow U. Expression of CD152 (CTLA-4) in children with autoimmune thyroiditis and +49 A/G polymorphism of exon 1 of the CTLA-4 gene. J Physiol Pharmacol 2009;60 Suppl 5:77-80.
14. Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmunediseases: A general susceptibility gene to autoiMunity?. Genes IMun 2000;1:170-84.
15. Waterhouse P, Penninger JM, TiMs E, Wakeham A, Shahinian A, Lee KP, et al. Lymphoproliferative disorders with early lethality in mice defi cient in Ctla-4. Science 1995;270:985-8.
16. Chistiakov DA, Savost'anov KV, Nosikov VV. CTLA-4 gene polymorphisms are associated with, and linked to, insulindependent diabetes mellitus in a Russian population. BMC Genet 2001;2:6.
17. Bouqbis L, Izaabel H, Akhayat O, Pérez-Lezaun A, Calafell F, Bertranpetit J, et al. Association of the CTLA-4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population. Genes IMun 2003;4:132-7. (Pubitemid 38967587)
18. Vaidya B, Pearce SH. The emerging role of the CTLA-4 gene in autoimmuneendocrinopathies. Eur J Endocrinol 2004;150:619-26. (Pubitemid 38786530)
19. Sambrook J, Russel DW. Molecular cloning. A Laboratory Manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press; 2001.
20. Abe T, Takino H, Yamasaki H, Ozaki M, Sera Y, Kondo H, et al. CTLA-4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese Type 1diabetes. Diabetes Res Clin Pract 1999;46:169-75. (Pubitemid 29509926)
21. Marron MP, Raffel LJ, Garchon HJ, Jacob CO, Serrano- Rios M, Martinez-Larrad MT, et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA-4 polymorphisms in multiple ethnic groups. Hum Mol Genet 1997;6:1275-82. (Pubitemid 27351067)
22. Donner H, Rau H, Walfi sh PG, Braun J, Siegmund T, Finke R, et al. CTLA-4 Alanine-17confers genetic susceptibility to Graves's disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 1997;82:143-6. (Pubitemid 27021285)
23. Cinek O, Sumnik DZ, Bendlovat B, Kolouskova S, Snajderova M, Vavrinec J. The CTLA 4 + 49 diamorphism is not accepted with type 1 diabetes in Czech children. Eur J IMunogenet 2001;29:219-22.